About PharmaCann
PharmaCann is a company based in Oak Park (United States) founded in 2014 was acquired by MedMen in October 2018. PharmaCann has raised $218.7 million across 14 funding rounds from investors including MedMen, XS Financial and The Cronos Group. The company has 979 employees as of December 31, 2021. PharmaCann has completed 1 acquisition, including LivWell.
- Headquarter Oak Park, United States
- Employees 979 as on 31 Dec, 2021
-
Sectors
Consumer
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$218.7 M (USD)
in 14 rounds
-
Latest Funding Round
$35 M (USD), Series D
Mar 28, 2024
-
Investors
MedMen
& 2 more
-
Employee Count
979
as on Dec 31, 2021
- Investments & Acquisitions
-
Acquired by
MedMen
(Oct 11, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of PharmaCann
Unlock access to complete
Funding Insights of PharmaCann
PharmaCann has successfully raised a total of $218.7M across 14 strategic funding rounds. The most recent funding activity was a Series D round of $35 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PharmaCann
PharmaCann has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include MedMen, XS Financial and The Cronos Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medicinal cannabis products are produced and supplied by the company.
|
Locked | Locked | Locked | |
|
Equipment leasing solutions are provided for cannabis and hemp sectors.
|
Locked | Locked | Locked | |
|
Comprehensive management and consulting services for marijuana operations are provided.
|
Locked | Locked | Locked |
Investor details for PharmaCann
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaCann
PharmaCann has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include LivWell.
Investment portfolio details for PharmaCann
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabis products, apparel, and accessories are distributed by LivWell.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for PharmaCann
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PharmaCann
Detailed financials for PharmaCann
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmacann Comparisons
Peer comparison for PharmaCann
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharmaCann
Detailed competitors of PharmaCann
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmacann
Complete news archive for PharmaCann
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaCann
PharmaCann was founded in 2014.
PharmaCann is headquartered in Oak Park, United States. It is registered at Oak Park, Illinois, United States.
Brett Novey is the current CEO of PharmaCann.
PharmaCann is a funded company, having raised a total of $218.7M across 14 funding rounds to date.
As of Dec 31, 2021, the latest employee count at PharmaCann is 979.
PharmaCann was founded in 2014 in Oak Park, United States, as a vertically integrated cannabis company. Cannabis is cultivated and processed into various products, which are then distributed through company-owned retail dispensaries. A range of cannabis products is provided to address diverse consumer needs. The full supply chain, from seed to sale, is managed within operations focused on the cannabis sector.
PharmaCann has made 1 acquisition, including LivWell.
PharmaCann has 3 investors. Key investors include MedMen, XS Financial, and The Cronos Group.